Citigroup Initiates Coverage On Qiagen with Neutral Rating, Announces $35 Price Target

Citigroup analyst Patrick Donnelly initiates coverage on Qiagen (NYSE:QGEN) with a Neutral rating and a $35 price target.

Benzinga · 01/07/2020 12:16

Citigroup analyst Patrick Donnelly initiates coverage on Qiagen (NYSE:QGEN) with a Neutral rating and a $35 price target.